The second tier of Intracranial Pressure Monitor segmentation distinguishes types of monitoring technology, each with unique cost structures, clinical performance, and adoption barriers. Invasive monitors dominate the segment, subdivided into external ventricular drains (EVDs) and fiber‑optic transducers; they provide direct cerebrospinal fluid pressure readings, justifying higher price points and extensive hospital‑level installations. Non‑invasive monitors—including transcranial Doppler‑derived indices, tympanic membrane displacement devices, and skull‑based strain‑gauge sensors—address settings where infection risk or procedural complexity precludes invasive approaches, expanding market reach into emergency departments and outpatient clinics. A further niche, semi‑invasive devices, such as intraparenchymal bolt systems, balance accuracy with reduced procedural burden, appealing to neurosurgical teams seeking rapid deployment without full EVD placement. The relative market contribution of each type aligns with clinical guidelines and reimbursement frameworks: invasive systems capture the largest share due to their entrenched role in critical care, while non‑invasive and semi‑invasive categories exhibit modest yet growing penetration as technology matures and regulatory pathways evolve.
